CH674008A5 - - Google Patents

Download PDF

Info

Publication number
CH674008A5
CH674008A5 CH2780/87A CH278087A CH674008A5 CH 674008 A5 CH674008 A5 CH 674008A5 CH 2780/87 A CH2780/87 A CH 2780/87A CH 278087 A CH278087 A CH 278087A CH 674008 A5 CH674008 A5 CH 674008A5
Authority
CH
Switzerland
Prior art keywords
group
hydrogen atom
alkyl
general formula
cycloalkyl
Prior art date
Application number
CH2780/87A
Other languages
English (en)
French (fr)
Inventor
Ian Harold Coates
William Leonard Mitchell
David Cedric Humber
James Angus Bell
George Blanch Ewan
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of CH674008A5 publication Critical patent/CH674008A5/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH2780/87A 1986-07-23 1987-07-22 CH674008A5 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868617994A GB8617994D0 (en) 1986-07-23 1986-07-23 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
CH674008A5 true CH674008A5 (ja) 1990-04-30

Family

ID=10601571

Family Applications (1)

Application Number Title Priority Date Filing Date
CH2780/87A CH674008A5 (ja) 1986-07-23 1987-07-22

Country Status (8)

Country Link
JP (1) JPS6335570A (ja)
BE (1) BE1000730A5 (ja)
CH (1) CH674008A5 (ja)
DE (1) DE3724322A1 (ja)
FR (1) FR2601951B1 (ja)
GB (2) GB8617994D0 (ja)
IT (1) IT1211667B (ja)
NL (1) NL8701728A (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225431A (en) * 1987-10-23 1993-07-06 Burroughs Wellcome Co. Therapeutic substituted indole compounds and compositions thereof
KR920700034A (ko) 1989-04-21 1992-02-19 예안 크라메르·한스 루돌프 하우스 5-ht₃수용체 길항제의 치료용도
CA2112487C (en) * 1991-06-26 2003-04-15 James W. Young Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron
ES2043535B1 (es) * 1992-03-13 1994-08-01 Vita Invest Sa Procedimiento para la obtencion de la 1,2,3,9-tetrahidro-9-metil-3-(2-metil-1h-imidazol-1-il)metil*-4h-carbazol-4-ona.
GB9214184D0 (en) * 1992-07-03 1992-08-12 Smithkline Beecham Plc Pharmaceuticals
CA2106642C (en) * 1992-10-14 2005-08-16 Peter Bod Carbazolone derivatives and process for preparing the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR920003064B1 (ko) * 1984-01-25 1992-04-13 글락소 그룹 리미티드 헤테로시클릭 화합물의 제조방법
AU583343B2 (en) * 1985-01-23 1989-04-27 Glaxo Group Limited Heterocyclic compounds
GB8518741D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8518745D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8518742D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process

Also Published As

Publication number Publication date
FR2601951A1 (fr) 1988-01-29
GB2192885B (en) 1990-02-07
IT1211667B (it) 1989-11-03
DE3724322A1 (de) 1988-01-28
NL8701728A (nl) 1988-02-16
GB8717353D0 (en) 1987-08-26
IT8748207A0 (it) 1987-07-22
GB2192885A (en) 1988-01-27
JPS6335570A (ja) 1988-02-16
GB8617994D0 (en) 1986-08-28
FR2601951B1 (fr) 1991-04-26
BE1000730A5 (fr) 1989-03-21

Similar Documents

Publication Publication Date Title
BE1001004A4 (fr) Nouvelles cetones tricycliques utiles comme medicaments, procede et intermediaires pour leur preparation.
CH664152A5 (fr) Derives de tetrahydrocarbazolones.
JP2941309B2 (ja) 化合物
FR2690919A1 (fr) Dérivés de l'indole.
WO2001055130A2 (fr) Derives de 1,3-dihydro-2h-indol-2-one et leur utilisation en tant que ligands des recepteurs v1b ou v1b et v1a de l'arginine-vasopressine
CZ304420B6 (cs) 2-Oxo-1-pyrrolidinové deriváty, způsob jejich přípravy a jejich použití
LU87414A1 (fr) Derives de l'adenosine
CA2542727A1 (fr) Derives de n-[phenyl(pyrrolidin-2-yl)methyl]benzamide, et n-[[azepan-2-yl)phenylmethyl]benzamide, leur preparation et leur application en therapeutique
FR2722190A1 (fr) Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant
CH667454A5 (fr) Derives d'indoles.
FR2495153A1 (fr) Nouvelles dibenzazepines, leur preparation et leur application comme medicaments
EP0677042A1 (fr) Ligands selectifs des recepteurs 5ht 1d?-5ht 1b? derives d'indole-piperazine utiles comme medicaments
FR2930249A1 (fr) Nouveaux derives de 3-aminoalkyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique.
LU85725A1 (fr) Nouvelles 8alpha-acylaminoergolines,leur preparation et leur utilisation comme medicaments
CA1095047A (fr) Procede de preparation de nouveaux derives du 1,4- benzodioxane
EP0004494B1 (fr) Nouveaux dérivés de 1,3-dihydro 3-(1-(2-(2,3-dihydro 1,4-benzo-dioxin-2-yl)2-hydroxy éthyl)pipéridin-4-yl)2H-indol 2-one, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant
CH674008A5 (ja)
CA2378628C (fr) Nouveaux derives d'indenoindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
LU87129A1 (fr) Nouvel acide piperazinecarboxylique,sa preparation et son utilisation comme medicament
EP0628045A1 (fr) Derives de pyrazolopyrimidines antagonistes des recepteurs a l'angiotensine ii
CH678149A5 (ja)
LU82235A1 (fr) Phenylmorphanes, intermediaires et procedes de synthese, et leur utilisation therapeutique
EP1119564B1 (fr) Derives d'aryl- 4-fluoro-4- (2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl -methanone comme agonistes du recepteur 5-ht1
FR2575159A1 (fr) Nouvelles 8a-acylaminoergolines, leur preparation, leur utilisation comme medicaments et les compositions pharmaceutiques les contenant
FR2609715A1 (fr) Nouveaux diazepinoindoles, leur preparation et leur utilisation comme medicaments

Legal Events

Date Code Title Description
PL Patent ceased